UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1

Leukemia, 2010-06, Vol.24 (6), p.1128-1138

TEFFERI, A

2010

Volltextzugriff (PDF)

Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors

Blood cancer journal (New York), 2015-11, Vol.5 (11), p.e366-e366

2015

Volltextzugriff (PDF)

Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms

Leukemia, 2008-01, Vol.22 (1), p.14-22

2008

Volltextzugriff (PDF)

Nilotinib treatment-associated accelerated atherosclerosis: when is the risk justified?

Leukemia, 2013-09, Vol.27 (9), p.1939-1940

Tefferi, A

2013

Volltextzugriff (PDF)

The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases

Leukemia, 2014-03, Vol.28 (3), p.485-496

2014

Volltextzugriff (PDF)

CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons

Leukemia, 2014-07, Vol.28 (7), p.1472-1477

2014

Volltextzugriff (PDF)

Pathogenesis of Myelofibrosis With Myeloid Metaplasia

Journal of clinical oncology, 2005-11, Vol.23 (33), p.8520-8530

TEFFERI, Ayalew

2005

Volltextzugriff (PDF)

Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia

Blood cancer journal (New York), 2016-02, Vol.6 (2), p.e393-e393

2016

Volltextzugriff (PDF)

The history of myeloproliferative disorders: before and after Dameshek

Leukemia, 2008-01, Vol.22 (1), p.3-13

TEFFERI, A

2008

Volltextzugriff (PDF)

An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms

Leukemia, 2014-07, Vol.28 (7), p.1407-1413

2014

Volltextzugriff (PDF)

CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients

Leukemia, 2014-07, Vol.28 (7), p.1494-1500

2014

Volltextzugriff (PDF)

Personalized management of essential thrombocythemia-application of recent evidence to clinical practice

Leukemia, 2013-08, Vol.27 (8), p.1617-1620

2013

Volltextzugriff (PDF)

Mutations galore in myeloproliferative neoplasms: Would the real Spartacus please stand up?

Leukemia, 2011-07, Vol.25 (7), p.1059-1063

Tefferi, A

2011

Volltextzugriff (PDF)

Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: differences in phenotype and prognostic impact

Leukemia, 2014-07, Vol.28 (7), p.1568-1570

2014

Volltextzugriff (PDF)

Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group

Leukemia, 2015-11, Vol.29 (11), p.2126-2133

2015

Volltextzugriff (PDF)

Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis

Leukemia, 2013-06, Vol.27 (6), p.1322-1327

2013

Volltextzugriff (PDF)

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Blood, 2009-07, Vol.114 (5), p.937-951

2009

Volltextzugriff (PDF)

The 2016 revision of WHO classification of myeloproliferative neoplasms: Clinical and molecular advances

Blood reviews, 2016-11, Vol.30 (6), p.453-459

2016

Volltextzugriff (PDF)

The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients

Leukemia, 2014-09, Vol.28 (9), p.1804-1810

2014

Volltextzugriff (PDF)

Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal

Leukemia, 2008-07, Vol.22 (7), p.1299-1307

2008

Volltextzugriff (PDF)

CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia

Leukemia, 2013-09, Vol.27 (9), p.1870-1873

2013

Volltextzugriff (PDF)

Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients

Blood cancer journal (New York), 2017-12, Vol.7 (12), p.662-662, Article 662

2017

Volltextzugriff (PDF)

ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients

Leukemia, 2014-11, Vol.28 (11), p.2206-2212

2014

Volltextzugriff (PDF)

Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study

Leukemia, 2013-09, Vol.27 (9), p.1874-1881

2013

Volltextzugriff (PDF)

Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms

Leukemia, 2011-07, Vol.25 (7), p.1200-1202

2011

Volltextzugriff (PDF)

1 – 25 von 2.008

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.897)
Mit Volltextzugriff
(1.860)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(2.008)

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.162)
Life Sciences & Biomedicine
(1.130)
Humans
(1.071)
Hematology
(907)
Male
(545)
Female
(543)
Middle Aged
(499)
Aged
(451)
Oncology
(444)
Biological And Medical Sciences
(425)
Medical Sciences
(425)
Adult
(399)
Hematologic And Hematopoietic Diseases
(324)
Mutation
(318)
Prognosis
(277)
Aged, 80 And Over
(258)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(256)
Leukemia
(185)
Myelofibrosis
(178)
Janus Kinase 2 - Genetics
(166)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1

Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors

Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms

Nilotinib treatment-associated accelerated atherosclerosis: when is the risk justified?

The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases

CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons

Pathogenesis of Myelofibrosis With Myeloid Metaplasia

Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia

The history of myeloproliferative disorders: before and after Dameshek

An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms

CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients

Personalized management of essential thrombocythemia-application of recent evidence to clinical practice

Mutations galore in myeloproliferative neoplasms: Would the real Spartacus please stand up?

Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: differences in phenotype and prognostic impact

Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group

Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

The 2016 revision of WHO classification of myeloproliferative neoplasms: Clinical and molecular advances

The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients

Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal

CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia

Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients

ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients

Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study

Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms

Suchergebnisse filtern